Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash	$ 62,282	$ 166,859
Total current assets	62,282	166,859
OTHER ASSETS
Right of first refusal agreement cost (less accumulated amortization of $23,333 and $19,583)	1,667	5,417
Total assets	63,949	172,276
CURRENT LIABILITIES
Accounts payable	6,418	6,094
Accrued interest	72,669	55,627
Accrued officers’ compensation	350,350	340,350
Notes payable to third parties	171,437	171,437
Total current liabilities and total liabilities	860,874	833,508
STOCKHOLDERS’ (DEFICIENCY)
Preferred stock; 19,000,000 shares authorized, $.001 par value: Series A Convertible Preferred-issued and outstanding 9,111,998 and 9,111,998 shares, respectively	9,112	9,112
Common stock; 2,000,000,000 shares authorized, $.001 par value, as of September 30, 2024 and December 31, 2023, there are 804,638,436 shares outstanding, respectively	804,639	804,639
Additional paid-in capital	3,006,321	3,006,321
Accumulated deficit	(4,616,997)	(4,481,304)
Total stockholders’ (deficiency)	(796,925)	(661,232)
Total liabilities and stockholders’ (deficiency)	63,949	172,276
Related Party [Member]
CURRENT LIABILITIES
Loans payable to related parties	$ 260,000	$ 260,000